ChartRow logo
Share this page
BEAM
$23.47-5.10%
as of close, Oct 16, 2026
☾ AH $23.47 -5.10%
PeersMRNALLYMDTUNHJNJTMO

Beam Therapeutics Inc. trailing returns

How Beam Therapeutics Inc. (BEAM) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-5.1%+0.0%-5.1%—
5 days-8.7%+0.0%-8.7%-8.7%Oct 16
1 month+1.6%+0.0%+1.6%-9.5%Oct 16
YTD-15.3%+0.0%-15.3%-39.1%Sep 16
1 year-9.0%+0.0%-9.0%-39.1%Sep 2026
5 years-24.1%+0.0%-24.1%-74.8%-85.3%Apr 2025
Since inception (2020)+3.4%+0.0%+3.4%+25.2%-89.1%Apr 2025

Growth of BEAM#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-24.1%/year · -74.8%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in BEAM's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Beam Therapeutics Inc.'s return since inception?
Since 2020, Beam Therapeutics Inc. (BEAM) has compounded at about +3.4% a year — +25.2% in total.

More on Beam Therapeutics Inc.